跳至主要内容
临床试验/ACTRN12618001691235
ACTRN12618001691235终止未知

Optimal Breath-hold technique for Upper-abdominal & thoracic Radiotherapy in patients with liver, pancreas, kidney, adrenal gland & lung cancer – Deep-inhale, Inhale or Exhale? Investigating stability, reproducibility, patient experience & treatment efficiency (BURDIE)

Austin Health0 个研究点目标入组 24 人开始时间: 2018年10月12日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
Austin Health
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Eligible for standard fractionated or SABR treatment to liver, kidney, adrenal, pancreas or lung (SABR only) per standard departmental policy
  • 2. Informed consent
  • 3. Aged >18 years
  • 4. English speaking, or able to follow instructions in English
  • 5. Eligible for breath-hold technique based on radiation oncologist assessment. Considerations may include but are not limited to:
  • a) Patient able to voluntarily hold their breath for greater than 15 seconds when comfortably seated
  • b) Patient of good performance status, ECOG 0-2
  • c) Patient able to lay in treatment position for greater than 45 minutes

排除标准

  • 1. Unable to consent/withdrawal of consent/decline consent
  • 2. Non-English Speaking or unable to follow spoken English instructions
  • 3. Ineligible for any breath-hold technique based on radiation oncologist assessment & criteria outlined in study methods

研究者

发起方
Austin Health

相似试验